Current:Home > StocksAttorneys for state of Utah ask parole board to keep death sentence for man convicted in 1998 murder -Wealthify
Attorneys for state of Utah ask parole board to keep death sentence for man convicted in 1998 murder
View
Date:2025-04-14 11:43:54
Attorneys for the state of Utah are expected on Tuesday to urge a parole board to deny a death row inmate’s request for his life to be spared ahead of his scheduled Aug. 8 execution.
Representatives of the 49-year-old victim, Claudia Benn, were scheduled to testify before both sides deliver their closing arguments during the commutation hearing at the Utah State Correctional Facility in Salt Lake City.
Inmate Taberon Dave Honie testified Monday that he wasn’t in his “right mind” when he killed his girlfriend’s mother in 1998 after a day of heavy drinking and drug use. He asked the five-member parole board to commute his sentence to life in prison.
Utah Board of Pardons & Parole Chairman Scott Stephenson said a decision would be made “as soon as practical” after the parole board hearing.
Honie told the Utah parole board that he never planned to kill Benn and doesn’t remember much about the killing, which happened when Benn’s three grandchildren — including Honie’s 2-year-old daughter — were in her home.
“I earned my place in prison. What I’m asking today for this board to consider is ‘Would you allow me to exist?’,” he said.
Attorneys for the state have urged the board to reject the request for a lesser sentence. They described his commutation petition as a “deflection of responsibility that never once acknowledges any of the savage acts he inflicted on Claudia or her granddaughters.”
The execution would be Utah’s first since Ronnie Lee Gardner was killed by firing squad in 2010, according to the state Department of Corrections.
Honie was convicted in 1999 of aggravated murder.
After decades of failed appeals, his execution warrant was signed last month despite defense objections to the planned lethal drug combination of the sedative ketamine, the anesthetic fentanyl and potassium chloride to stop his heart. Honie’s attorneys sued, and corrections officials agreed to switch to pentobarbital.
veryGood! (9)
Related
- Bill Belichick's salary at North Carolina: School releases football coach's contract details
- Sacramento mayor trades barbs with DA over 'unprecedented' homeless crisis
- Fire at a Texas apartment complex causes hundreds of evacuations but no major injuries are reported
- This Samsung Galaxy Z Fold 5 pre-order deal saves you up to $1,050
- Former longtime South Carolina congressman John Spratt dies at 82
- Broncos QB Russell Wilson, singer Ciara expecting third child
- Mega Millions is up to $1.58B. Here's why billion-dollar jackpots are now more common.
- Run-D.M.C's 'Walk This Way' brought hip-hop to the masses and made Aerosmith cool again
- Don't let hackers fool you with a 'scam
- Jay-Z’s Made In America fest canceled due to ‘severe circumstances outside of production control’
Ranking
- Travis Hunter, the 2
- Here's when you should — and shouldn't — use autopay for your bills
- Teen sisters have been missing from Michigan since June. The FBI is joining the search.
- Raven-Symoné Says Dad Suggested Strongly She Get Breast Reduction, Liposuction Before Age 18
- Travis Hunter, the 2
- 3 fishermen plucked from Atlantic waters off Nantucket by Coast Guard helicopter crew
- This Samsung Galaxy Z Fold 5 pre-order deal saves you up to $1,050
- Petition to recall SW town’s mayor submitted to Jeff Davis Registrar of Voters
Recommendation
Retirement planning: 3 crucial moves everyone should make before 2025
Suit up With This Blazer and Pants Set That’s Only $41 and Comes in 9 Colors
Run-D.M.C's 'Walk This Way' brought hip-hop to the masses and made Aerosmith cool again
How pop culture framed the crack epidemic
'Squid Game' without subtitles? Duolingo, Netflix encourage fans to learn Korean
More than 40,000 Americans are genetically related to 27 enslaved people excavated from Maryland
How pop culture framed the crack epidemic
Wegovy patients saw 20% reduction in cardiovascular risks, drugmaker says